Bendamustine: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

11

Conditions studied

13

US states with sites

4

Countries

Phase breakdown

Phase 1 2 Phase 2 1

Conditions being studied

Condition	Trials
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)	1
Idiopathic Inflammatory Myositis (IIM)	1
Lupus	1
Lupus Nephritis	1
Multiple Sclerosis	1
Multiple Sclerosis (MS) Primary Progressive	1
Multiple Sclerosis (MS) Secondary Progressive	1
Primary Progressive Multiple Sclerosis	1
Secondary Progressive Multiple Sclerosis (SPMS)	1
Systemic Lupus Erythematosus (SLE)	1
Systemic Sclerosis (SSc)	1

Recruiting trials involving Bendamustine

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
NCT06308978 · Phase: Phase 1 · Ages: 12 Years to 70 Years · Sex: All (male and female) · 21 locations
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
NCT07477639 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations

Common questions

How many recruiting trials involve Bendamustine?

2 recruiting trials across 11 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.